Chaudhary Rakesh P, Kangasniemi Kim, Takahashi Masaya, Mohanty Samarendra K, Koymen Ali R
Department of Physics, University of Texas at Arlington; Arlington, TX 76019, USA.
Advanced Imaging Research Center, Radiology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
J Funct Biomater. 2017 Oct 9;8(4):46. doi: 10.3390/jfb8040046.
The aim of this study is to fabricate a hybrid composite of iron (Fe) core-carbon (C) shell nanoparticles with enhanced magnetic properties for contrast enhancement in magnetic resonance imaging (MRI). These new classes of magnetic core-shell nanoparticles are synthesized using a one-step top-down approach through the electric plasma discharge generated in the cavitation field in organic solvents by an ultrasonic horn. Transmission electron microscopy (TEM) observations revealed the core-shell nanoparticles with 10-85 nm in diameter with excellent dispersibility in water without any agglomeration. TEM showed the structural confirmation of Fe nanoparticles with body centered cubic (bcc) crystal structure. Magnetic multi-functional hybrid composites of Fe core-C shell nanoparticles were then evaluated as negative MRI contrast agents, displaying remarkably high transverse relaxivity (₂) of 70 mM·S at 7 T. This simple one-step synthesis procedure is highly versatile and produces desired nanoparticles with high efficacy as MRI contrast agents and potential utility in other biomedical applications.
本研究的目的是制备具有增强磁性的铁(Fe)核-碳(C)壳纳米颗粒的混合复合材料,用于磁共振成像(MRI)中的对比度增强。这些新型磁核壳纳米颗粒是通过一步自上而下的方法合成的,该方法利用超声换能器在有机溶剂的空化场中产生的电等离子体放电来实现。透射电子显微镜(TEM)观察显示,核壳纳米颗粒的直径为10-85nm,在水中具有优异的分散性,无任何团聚现象。TEM显示了具有体心立方(bcc)晶体结构的Fe纳米颗粒的结构确认。然后,对Fe核-C壳纳米颗粒的磁性多功能混合复合材料作为阴性MRI造影剂进行了评估,在7T时显示出高达70 mM·S的横向弛豫率(₂)。这种简单的一步合成方法具有高度的通用性,能够高效地制备出所需的纳米颗粒,作为MRI造影剂具有很高的功效,并在其他生物医学应用中具有潜在的用途。
J Funct Biomater. 2017-10-9
J Phys Chem B. 2006-4-13
J Colloid Interface Sci. 2010-1-18
ACS Appl Mater Interfaces. 2021-4-14
J Nanosci Nanotechnol. 2010-4
Adv Sci (Weinh). 2021-6
Sci Technol Adv Mater. 2015-4-28
Sci Rep. 2014-6-18
Nanoscale Res Lett. 2012-1-5
Adv Drug Deliv Rev. 2011-4-5
Adv Drug Deliv Rev. 2009-11-10